Cargando…

The Association of Human Leucocyte Antigen (HLA) Class I and II Genes with Cutaneous and Visceral Leishmaniasis in Iranian Patients: A Preliminary Case-Control Study

BACKGROUND: Leishmaniasis is currently considered a re-emerging or emerging infection based on the geographic region. The outcome of leishmaniasis vastly depends on Leishmania-host interaction. This preliminary study aimed to show the association of human leukocyte antigen (HLA) class I and II genes...

Descripción completa

Detalles Bibliográficos
Autores principales: Eimanzadeh, Mitra, Mohebali, Mehdi, Zarrabi, Morteza, Foroushani, Abbas Rahimi, Kazemi, Mohammad, Hajjaran, Homa, Zarei, Zabih, Kakooei, Zahra, Akhoundi, Behnaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423905/
https://www.ncbi.nlm.nih.gov/pubmed/37583643
http://dx.doi.org/10.18502/ijpa.v18i2.13181
_version_ 1785089554599903232
author Eimanzadeh, Mitra
Mohebali, Mehdi
Zarrabi, Morteza
Foroushani, Abbas Rahimi
Kazemi, Mohammad
Hajjaran, Homa
Zarei, Zabih
Kakooei, Zahra
Akhoundi, Behnaz
author_facet Eimanzadeh, Mitra
Mohebali, Mehdi
Zarrabi, Morteza
Foroushani, Abbas Rahimi
Kazemi, Mohammad
Hajjaran, Homa
Zarei, Zabih
Kakooei, Zahra
Akhoundi, Behnaz
author_sort Eimanzadeh, Mitra
collection PubMed
description BACKGROUND: Leishmaniasis is currently considered a re-emerging or emerging infection based on the geographic region. The outcome of leishmaniasis vastly depends on Leishmania-host interaction. This preliminary study aimed to show the association of human leukocyte antigen (HLA) class I and II genes with healed and non-healed cutaneous leishmaniasis (CL), and symptomatic and asymptomatic visceral leishmaniasis (VL) compared with control groups in Iran. METHODS: Ninety-five people, including 31 patients versus 64 individuals in the control group, were enrolled. Among them, 20 patients had confirmed CL based on amastigote observation, 10 had improved CL and 10 non-healed CL. Eleven patients were suffering from confirmed VL based on direct agglutination test (Five asymptomatic and six symptomatic VL cases). Besides, they were residents in an endemic area of VL in the northwest of Iran. To select a control group, it was ensured that they had no history of leishmaniasis. Peripheral blood samples were collected from each patient. After DNA extraction, HLA typing was conducted using polymerase chain reaction - sequence-specific priming (PCR-SSP). Subsequently, data were statistically analyzed by SPSS. RESULTS: There was a statistical relationship between the presence of HLA-A26 and CL, healed CL and the existence of the B38 allele, C1 allele and symptomatic VL, as well as B1.4 allele and asymptomatic VL (P<0.05). CONCLUSION: This primary finding indicates that several HLA genes have a potential role in the susceptibility of Iranian people to CL and VL.
format Online
Article
Text
id pubmed-10423905
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-104239052023-08-15 The Association of Human Leucocyte Antigen (HLA) Class I and II Genes with Cutaneous and Visceral Leishmaniasis in Iranian Patients: A Preliminary Case-Control Study Eimanzadeh, Mitra Mohebali, Mehdi Zarrabi, Morteza Foroushani, Abbas Rahimi Kazemi, Mohammad Hajjaran, Homa Zarei, Zabih Kakooei, Zahra Akhoundi, Behnaz Iran J Parasitol Original Article BACKGROUND: Leishmaniasis is currently considered a re-emerging or emerging infection based on the geographic region. The outcome of leishmaniasis vastly depends on Leishmania-host interaction. This preliminary study aimed to show the association of human leukocyte antigen (HLA) class I and II genes with healed and non-healed cutaneous leishmaniasis (CL), and symptomatic and asymptomatic visceral leishmaniasis (VL) compared with control groups in Iran. METHODS: Ninety-five people, including 31 patients versus 64 individuals in the control group, were enrolled. Among them, 20 patients had confirmed CL based on amastigote observation, 10 had improved CL and 10 non-healed CL. Eleven patients were suffering from confirmed VL based on direct agglutination test (Five asymptomatic and six symptomatic VL cases). Besides, they were residents in an endemic area of VL in the northwest of Iran. To select a control group, it was ensured that they had no history of leishmaniasis. Peripheral blood samples were collected from each patient. After DNA extraction, HLA typing was conducted using polymerase chain reaction - sequence-specific priming (PCR-SSP). Subsequently, data were statistically analyzed by SPSS. RESULTS: There was a statistical relationship between the presence of HLA-A26 and CL, healed CL and the existence of the B38 allele, C1 allele and symptomatic VL, as well as B1.4 allele and asymptomatic VL (P<0.05). CONCLUSION: This primary finding indicates that several HLA genes have a potential role in the susceptibility of Iranian people to CL and VL. Tehran University of Medical Sciences 2023 /pmc/articles/PMC10423905/ /pubmed/37583643 http://dx.doi.org/10.18502/ijpa.v18i2.13181 Text en Copyright © 2023 Eimanzadeh et al. Published by Tehran University of Medical Sciences. https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (https://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited.
spellingShingle Original Article
Eimanzadeh, Mitra
Mohebali, Mehdi
Zarrabi, Morteza
Foroushani, Abbas Rahimi
Kazemi, Mohammad
Hajjaran, Homa
Zarei, Zabih
Kakooei, Zahra
Akhoundi, Behnaz
The Association of Human Leucocyte Antigen (HLA) Class I and II Genes with Cutaneous and Visceral Leishmaniasis in Iranian Patients: A Preliminary Case-Control Study
title The Association of Human Leucocyte Antigen (HLA) Class I and II Genes with Cutaneous and Visceral Leishmaniasis in Iranian Patients: A Preliminary Case-Control Study
title_full The Association of Human Leucocyte Antigen (HLA) Class I and II Genes with Cutaneous and Visceral Leishmaniasis in Iranian Patients: A Preliminary Case-Control Study
title_fullStr The Association of Human Leucocyte Antigen (HLA) Class I and II Genes with Cutaneous and Visceral Leishmaniasis in Iranian Patients: A Preliminary Case-Control Study
title_full_unstemmed The Association of Human Leucocyte Antigen (HLA) Class I and II Genes with Cutaneous and Visceral Leishmaniasis in Iranian Patients: A Preliminary Case-Control Study
title_short The Association of Human Leucocyte Antigen (HLA) Class I and II Genes with Cutaneous and Visceral Leishmaniasis in Iranian Patients: A Preliminary Case-Control Study
title_sort association of human leucocyte antigen (hla) class i and ii genes with cutaneous and visceral leishmaniasis in iranian patients: a preliminary case-control study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423905/
https://www.ncbi.nlm.nih.gov/pubmed/37583643
http://dx.doi.org/10.18502/ijpa.v18i2.13181
work_keys_str_mv AT eimanzadehmitra theassociationofhumanleucocyteantigenhlaclassiandiigeneswithcutaneousandvisceralleishmaniasisiniranianpatientsapreliminarycasecontrolstudy
AT mohebalimehdi theassociationofhumanleucocyteantigenhlaclassiandiigeneswithcutaneousandvisceralleishmaniasisiniranianpatientsapreliminarycasecontrolstudy
AT zarrabimorteza theassociationofhumanleucocyteantigenhlaclassiandiigeneswithcutaneousandvisceralleishmaniasisiniranianpatientsapreliminarycasecontrolstudy
AT foroushaniabbasrahimi theassociationofhumanleucocyteantigenhlaclassiandiigeneswithcutaneousandvisceralleishmaniasisiniranianpatientsapreliminarycasecontrolstudy
AT kazemimohammad theassociationofhumanleucocyteantigenhlaclassiandiigeneswithcutaneousandvisceralleishmaniasisiniranianpatientsapreliminarycasecontrolstudy
AT hajjaranhoma theassociationofhumanleucocyteantigenhlaclassiandiigeneswithcutaneousandvisceralleishmaniasisiniranianpatientsapreliminarycasecontrolstudy
AT zareizabih theassociationofhumanleucocyteantigenhlaclassiandiigeneswithcutaneousandvisceralleishmaniasisiniranianpatientsapreliminarycasecontrolstudy
AT kakooeizahra theassociationofhumanleucocyteantigenhlaclassiandiigeneswithcutaneousandvisceralleishmaniasisiniranianpatientsapreliminarycasecontrolstudy
AT akhoundibehnaz theassociationofhumanleucocyteantigenhlaclassiandiigeneswithcutaneousandvisceralleishmaniasisiniranianpatientsapreliminarycasecontrolstudy
AT eimanzadehmitra associationofhumanleucocyteantigenhlaclassiandiigeneswithcutaneousandvisceralleishmaniasisiniranianpatientsapreliminarycasecontrolstudy
AT mohebalimehdi associationofhumanleucocyteantigenhlaclassiandiigeneswithcutaneousandvisceralleishmaniasisiniranianpatientsapreliminarycasecontrolstudy
AT zarrabimorteza associationofhumanleucocyteantigenhlaclassiandiigeneswithcutaneousandvisceralleishmaniasisiniranianpatientsapreliminarycasecontrolstudy
AT foroushaniabbasrahimi associationofhumanleucocyteantigenhlaclassiandiigeneswithcutaneousandvisceralleishmaniasisiniranianpatientsapreliminarycasecontrolstudy
AT kazemimohammad associationofhumanleucocyteantigenhlaclassiandiigeneswithcutaneousandvisceralleishmaniasisiniranianpatientsapreliminarycasecontrolstudy
AT hajjaranhoma associationofhumanleucocyteantigenhlaclassiandiigeneswithcutaneousandvisceralleishmaniasisiniranianpatientsapreliminarycasecontrolstudy
AT zareizabih associationofhumanleucocyteantigenhlaclassiandiigeneswithcutaneousandvisceralleishmaniasisiniranianpatientsapreliminarycasecontrolstudy
AT kakooeizahra associationofhumanleucocyteantigenhlaclassiandiigeneswithcutaneousandvisceralleishmaniasisiniranianpatientsapreliminarycasecontrolstudy
AT akhoundibehnaz associationofhumanleucocyteantigenhlaclassiandiigeneswithcutaneousandvisceralleishmaniasisiniranianpatientsapreliminarycasecontrolstudy